PVX 009Alternative Names: PVX-009
Latest Information Update: 15 Sep 2017
Price : *
At a glance
- Originator PepVax, Inc.
- Class Antineoplastics; Immunotherapies
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Breast cancer